title: Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
abstract: In antigen-presenting cells (APCs), loading of major histocompatibility complex class II (MHC II) molecules with peptides is regulated by invariant chain (Ii), which blocks MHC II antigen-binding sites in pre-endosomal compartments. Several molecules then act upon MHC II molecules in endosomes to facilitate peptide loading: Ii-degrading proteases, the peptide exchange factor, human leukocyte antigen-DM (HLA-DM), and its modulator, HLA-DO (DO). Here, we review our findings arguing that DM stabilizes a globally altered conformation of the antigen-binding groove by binding to a lateral surface of the MHC II molecule. Our data imply changes in the interactions between specificity pockets and peptide side chains, complementing data from others that suggest DM affects hydrogen bonds. Selective weakening of peptide/MHC interactions allows DM to alter the peptide repertoire. We also review our studies in cells that highlight the ability of several factors to modulate surface expression of MHC II molecules via post-Golgi mechanisms; these factors include MHC class II-associated Ii peptides (CLIP), DM, and microbial products that modulate MHC II traffic from endosomes to the plasma membrane. In this context, we discuss possible mechanisms by which the association of some MHC II alleles with autoimmune diseases may be linked to their low CLIP affinity.
authors.affiliation: Division of Pediatric Immunology and Transplantation Biology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94705, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Busch
authors.forename: Cornelia H
authors.initials: CH
authors.lastname: Rinderknecht
authors.forename: Sujin
authors.initials: S
authors.lastname: Roh
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Lee
authors.forename: James J
authors.initials: JJ
authors.lastname: Harding
authors.forename: Timo
authors.initials: T
authors.lastname: Burster
authors.forename: Tara M C
authors.initials: TM
authors.lastname: Hornell
authors.forename: Elizabeth D
authors.initials: ED
authors.lastname: Mellins
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000276:immunology*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology / Q000378:metabolism; D015551:Autoimmunity / Q000276:immunology; D006681:HLA-D Antigens / Q000276:immunology* / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D018832:Molecular Chaperones / Q000276:immunology*; D010455:Peptides / Q000276:immunology / Q000378:metabolism; D011485:Protein Binding / Q000276:immunology; D011499:Protein Processing, Post-Translational / Q000276:immunology; D020836:Protein Structure, Quaternary
chemical_list: D000944:Antigens, Differentiation, B-Lymphocyte; D006681:HLA-D Antigens; C084245:HLA-DM antigens; D000949:Histocompatibility Antigens Class II; D018832:Molecular Chaperones; D010455:Peptides; C045084:invariant chain